| Romidepsin studied in …STUDIED_INderived85 of 85show fewer |
|---|
| → studied in | NCT01947140Phase 1/Phase 2 · terminated Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies · 85 trials list this drug (5 active) | — | — | Lymphoma,Hodgkin Lymphoma,Multiple Myeloma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04447027Phase 1 · completed Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies · 85 trials list this drug (5 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06963346Phase 1 · recruiting Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents · 85 trials list this drug (5 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02232516Phase 2 · completed Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma · 85 trials list this drug (5 active) | — | — | Anaplastic Large Cell Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Hepatosplenic T-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03703375Phase 3 · completed Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma · 85 trials list this drug (5 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03547700Phase 1/Phase 2 · terminated Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL) · 85 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02783625Phase 1 · completed Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas · 85 trials list this drug (5 active) | — | — | Lymphoma,T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03593018Phase 3 · completed Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL · 85 trials list this drug (5 active) | — | — | Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01846390Phase 1 · completed Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma · 85 trials list this drug (5 active) | — | — | Diffuse Large B-Cell Lymphoma,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04747236Phase 2 · recruiting Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL · 85 trials list this drug (5 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03278782Phase 1/Phase 2 · active not recruiting Study of Pembrolizumab (MK-3475) in Combination With Romidepsin · 85 trials list this drug (5 active) | — | — | Anaplastic Large Cell Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02512172Phase 1 · completed A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer · 85 trials list this drug (5 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393794Phase 1/Phase 2 · active not recruiting Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) · 85 trials list this drug (5 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04257448Phase 1/Phase 2 · completed Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer · 85 trials list this drug (5 active) | — | — | Pancreatic Carcinoma,Pancreatic Adenocarcinoma,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02512497Phase 1 · completed Romidepsin Maintenance After Allogeneic Stem Cell Transplantation · 85 trials list this drug (5 active) | — | — | T Lymphoblastic Leukemia/Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,T-Cell Prolymphocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03432741Phase 1 · terminated Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer · 85 trials list this drug (5 active) | — | — | Breast Carcinoma,Hodgkin Lymphoma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01938833Phase 1/Phase 2 · terminated Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer · 85 trials list this drug (5 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma,Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02616965Phase 1 · completed A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma · 85 trials list this drug (5 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01638533Phase 1 · completed Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction · 85 trials list this drug (5 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Solid Neoplasm,Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04774068Phase 1 · completed Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas · 85 trials list this drug (5 active) | — | — | Anaplastic Large Cell Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,T-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01755975Phase 1/Phase 2 · completed Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma · 85 trials list this drug (5 active) | — | — | Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01998035Phase 1/Phase 2 · terminated Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies · 85 trials list this drug (5 active) | — | — | Lymphoma,Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02341014Phase 1/Phase 2 · completed Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas · 85 trials list this drug (5 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020202Phase 2 · completed FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer · 85 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03742921completed ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma · 85 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03534180Phase 2 · completed Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma · 85 trials list this drug (5 active) | — | — | Anaplastic Large Cell Lymphoma,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104884Phase 2 · terminated FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma · 85 trials list this drug (5 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04639843Phase 1 · withdrawn Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell Lymphoma · 85 trials list this drug (5 active) | — | — | Adult T-Cell Leukemia/Lymphoma,Hepatosplenic T-Cell Lymphoma,Enteropathy-Associated T-Cell Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03770000Phase 1/Phase 2 · completed Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma · 85 trials list this drug (5 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03141203Phase 1/Phase 2 · completed Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients · 85 trials list this drug (5 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03161223Phase 1/Phase 2 · recruiting Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma · 85 trials list this drug (5 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084682Phase 2 · completed Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · 85 trials list this drug (5 active) | — | — | Head and Neck Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma,Hypopharyngeal Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02181218Phase 1 · completed Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas · 85 trials list this drug (5 active) | — | — | Lymphoma,Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04233697Phase 1 · withdrawn Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma · 85 trials list this drug (5 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01902225Phase 1 · completed Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma · 85 trials list this drug (5 active) | — | — | Lymphoma,Cutaneous Lymphoma,T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00426764Phase 2 · completed A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma · 85 trials list this drug (5 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445340Phase 1 · terminated Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma · 85 trials list this drug (5 active) | — | — | Neoplasm,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00094978Phase 1 · terminated Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum · 85 trials list this drug (5 active) | — | — | Esophageal Neoplasm,Malignant Mesothelioma,Lung Non-Small Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00765102Phase 2 · terminated Trial of Romidepsin and Bortezomib for Multiple Myeloma · 85 trials list this drug (5 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01324310Phase 1 · completed Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer · 85 trials list this drug (5 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01324323Phase 1 · completed Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer · 85 trials list this drug (5 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01353664Phase 2 · completed A Rollover Study for Patients Who Participated in Other Romidepsin Protocols · 85 trials list this drug (5 active) | — | — | Malignant Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00106301Phase 2 · completed Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228 · 85 trials list this drug (5 active) | — | — | Prostate Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00106418Phase 2 · completed A Research Study for Patients With Prostate Cancer · 85 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00106431Phase 2 · completed A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL) · 85 trials list this drug (5 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00379639Phase 1 · completed A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors · 85 trials list this drug (5 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00106613Phase 2 · completed A Research Study for Patients With Metastatic Renal Cell Carcinoma · 85 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00037817Phase 1 · completed Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies · 85 trials list this drug (5 active) | — | — | Malignant Esophageal Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01738594Phase 1 · terminated Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma · 85 trials list this drug (5 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01456039Phase 1/Phase 2 · completed A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL) · 85 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01897012Phase 1 · completed Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas · 85 trials list this drug (5 active) | — | — | B-Cell Non-Hodgkin Lymphoma,Hodgkin Lymphoma,Burkitt Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02061449Phase 1 · terminated Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma · 85 trials list this drug (5 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03355768Phase 3 · withdrawn Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL · 85 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01590732Phase 1 · completed Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma · 85 trials list this drug (5 active) | — | — | Anaplastic Large Cell Lymphoma,Hepatosplenic T-Cell Lymphoma,Mycosis Fungoides+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01482962Phase 3 · completed Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma · 85 trials list this drug (5 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01979276Phase 1/Phase 2 · terminated Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma · 85 trials list this drug (5 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00963274Phase 1 · completed Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · 85 trials list this drug (5 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112463Phase 2 · completed Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma · 85 trials list this drug (5 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Gastrointestinal Stromal Tumor,Malignant Peripheral Nerve Sheath Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00007345Phase 2 · completed Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma · 85 trials list this drug (5 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085540Phase 1/Phase 2 · completed FR901228 in Treating Patients With Recurrent High-Grade Gliomas · 85 trials list this drug (5 active) | — | — | Adult Anaplastic Astrocytoma,Adult Anaplastic Oligodendroglioma,Adult Giant Cell Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02757248Phase 1 · withdrawn Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL · 85 trials list this drug (5 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02281279Phase 1/Phase 2 · withdrawn Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma · 85 trials list this drug (5 active) | — | — | Hairy Cell Leukemia,Non-Hodgkin Lymphoma,Adult Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02296398completed Long-term Use of Romidepsin in Patients With CTCL · 85 trials list this drug (5 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062075Phase 2 · completed Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 85 trials list this drug (5 active) | — | — | Adult Acute Myeloid Leukemia,Acute Myeloid Leukemia with del(5q),Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019318Phase 1 · completed Depsipeptide in Treating Patients With Solid Tumors · 85 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066638Phase 2 · completed FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma · 85 trials list this drug (5 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098813Phase 2 · completed Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine · 85 trials list this drug (5 active) | — | — | Thyroid Gland Follicular Carcinoma,Malignant Thyroid Gland Neoplasm,Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00383565Phase 2 · terminated FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma · 85 trials list this drug (5 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00086827Phase 2 · completed Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer · 85 trials list this drug (5 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085527Phase 2 · withdrawn FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer · 85 trials list this drug (5 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01913119early Phase 1 · completed A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma · 85 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098527Phase 2 · terminated FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer · 85 trials list this drug (5 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm,Esophageal Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079443Phase 2 · terminated FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma · 85 trials list this drug (5 active) | — | — | Small Lymphocytic Lymphoma,Grade 1 Follicular Lymphoma,Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077337Phase 2 · completed FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer · 85 trials list this drug (5 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084461Phase 2 · terminated Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors · 85 trials list this drug (5 active) | — | — | Digestive System Neuroendocrine Tumor G1,Gastrin-Producing Neuroendocrine Tumor,Lung Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091195Phase 2 · terminated Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer · 85 trials list this drug (5 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077194Phase 2 · completed FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma · 85 trials list this drug (5 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114257Phase 1 · completed Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders · 85 trials list this drug (5 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00024180Phase 1 · completed FR901228 in Treating Patients With Hematologic Cancer · 85 trials list this drug (5 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098397Phase 2 · completed FR901228 in Treating Patients With Metastatic Breast Cancer · 85 trials list this drug (5 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053963Phase 1 · completed FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia · 85 trials list this drug (5 active) | — | — | Childhood Solid Neoplasm,Choroid Plexus Neoplasm,Childhood Central Nervous System Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087295Phase 2 · terminated S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium · 85 trials list this drug (5 active) | — | — | Malignant Bladder Neoplasm,Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00431990Phase 1/Phase 2 · unknown A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma · 85 trials list this drug (5 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042822Phase 2 · completed FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma · 85 trials list this drug (5 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00299351Phase 2 · unknown A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide. · 85 trials list this drug (5 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |